C4 Dynasty MMXX Icy Blue Razz is a pre-workout blend featuring a Dynasty Triple Citrulline Complex, CarnoSyn, and a Dynasty Triple Creatine Complex. It also contains caffeine and N-Acetyl L-Tyrosine. This product has an N+ Score of 63.
About This Product
C4 Dynasty MMXX Icy Blue Razz by Cellucor is a protein supplement containing 16 active ingredients. It has earned an N+ Score of 63/100 (Grade D).
Notable clinical-dose ingredients include CarnoSyn, Taurine.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
- +Rich formula with 16 active ingredients
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (16 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 5.000 Calorie(s) | N/A |
| Total Carbohydrates | 1.000 Gram(s) | N/A |
| CarnoSyn | 6.400 Gram(s) | Optimal |
| N-Acetyl L-Tyrosine | 400.000 mg | Under |
| Theacrine | 62.500 mg | N/A |
| Taurine | 1.000 Gram(s) | Optimal |
| elevATP | 150.000 mg | N/A |
| Caffeine Anhydrous | 350.000 mg | N/A |
| AstraGin | 50.000 mg | N/A |
| Dynasty Triple Citrulline Complex | 10.000 Gram(s) | N/A |
| Dynasty Triple Creatine Complex | 5.000 Gram(s) | N/A |
| PeakATP Adenosine 5'-Triphosphate Disodium Salt | 400.000 mg | N/A |
| AlphaSize 50% A-GPC | 200.000 mg | N/A |
| VasoDrive-AP Hydrolyzed Casein Lactotripeptides | 150.000 mg | N/A |
| Toothed Clubmoss (Huperzia serrata) aerial parts extract | 5.000 mg | N/A |
| Rauwolfia vomitoria root extract | 1.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.